FENNEC PHARMACEUTICALS INC. — Investor Relations & Filings
Filings indexed
762
across all filing types
Latest filing
2025-10-10
Regulatory Filings
Country
CA
Canada
Listing
US
FENC
Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of its proprietary product, PEDMARK®. PEDMARK is a unique formulation of sodium thiosulfate designed to reduce the risk of ototoxicity (permanent hearing loss) associated with cisplatin chemotherapy. The product is specifically indicated for pediatric patients with localized, non-metastatic solid tumors. The company's core mission is to address this significant unmet medical need in pediatric oncology, preventing lifelong hearing loss in children undergoing cancer treatment.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Regulatory Filings 2025 | 2025-10-10 | English | |
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-10-09 | English | |
| Director's Dealing 2025 | 2025-10-08 | English | |
| Director's Dealing 2025 | 2025-10-07 | English | |
| Regulatory Filings 2025 | 2025-10-06 | English | |
| Director's Dealing 2025 | 2025-10-01 | English |
Browse filings by year
25 years- 2026 22 filings
- 2025 97 filings
- 2024 99 filings
- 2023 49 filings
- 2022 35 filings
- 2021 26 filings
- 2020 36 filings
- 2019 29 filings
- 2018 39 filings
- 2017 43 filings
- 2016 11 filings
- 2015 10 filings
- 2014 30 filings
- 2013 19 filings
- 2012 11 filings
- 2011 27 filings
- 2010 42 filings
- 2009 15 filings
- 2008 17 filings
- 2007 63 filings
- 2006 15 filings
- 2005 16 filings
- 2004 9 filings
- 2003 1 filing
- 2002 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 11570462 | Regulatory Filings 2025 | 2025-10-10 | English | ||
| 11570463 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-10-09 | English | ||
| 11570464 | Director's Dealing 2025 | 2025-10-08 | English | ||
| 11570466 | Director's Dealing 2025 | 2025-10-07 | English | ||
| 11570465 | Regulatory Filings 2025 | 2025-10-06 | English | ||
| 11570467 | Director's Dealing 2025 | 2025-10-01 | English | ||
| 11570468 | Director's Dealing 2025 | 2025-10-01 | English | ||
| 11570469 | Director's Dealing 2025 | 2025-09-09 | English | ||
| 11570471 | Regulatory Filings 2025 | 2025-09-04 | English | ||
| 11570470 | Director's Dealing 2025 | 2025-09-04 | English | ||
| 11570474 | Director's Dealing 2025 | 2025-09-02 | English | ||
| 11570475 | Director's Dealing 2025 | 2025-09-02 | English | ||
| 11570473 | 10-Q | 2025-08-14 | English | ||
| 11570476 | Director's Dealing 2025 | 2025-08-05 | English | ||
| 11570477 | Regulatory Filings 2025 | 2025-08-05 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
FENNEC PHARMACEUTICALS INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35599/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35599 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35599 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35599 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35599}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for FENNEC PHARMACEUTICALS INC. (id: 35599)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.